Document is current
Any future updates will be listed below
-
Authors
Marabita, Manuela
Marchioretti, Caterina
Aravamudhan, Aishwarya
Zito, Simona
Falconieri, Antonella
Zuccaro, Emanuela
Andreotti, Roberta
Gambarotto, Lisa
Metti, Samuele
Tonellato, Marika
Adami, Valentina
Park, Kyung Ho
Gunthorpe, Martin J.
Large, Charles H.
Marasco, Agostino
Vianello, Sara
Rosati, Jessica
Belluzzi, Elisa
Pozzuoli, Assunta
Biz, Carlo
Ruggieri, Pietro
Basso, Manuela
Poletti, Angelo
Alvaro, Giuseppe
Sorarù, Gianni
Bonaldo, Paolo
Rossetto, Ornella
Pilati, Nadia
Pennuto, Maria
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 19 June 2025
First Online: 14 July 2025
Declarations
:
: All animal experiments were carried out according to KFDA guidelines for the care and use of laboratory animals and as approved by IACUC (IACUC number: KBIO-IACUC-2021-208) and local ethics committees (University of Padova) and the Ministry of Health (Italy). Analysis on human muscle biopsies was approved by the Ethical committee for Clinical Practice of the Azienda Ospedale Università of Padova and all subjects signed written informed consent in compliance with the Helsinki Declaration.
: All patients gave informed consent to study procedures, which were carried out in accordance with the Declaration of Helsinki.
: M.P. received support from Arvinas and Autifony. M.P. and M.B. are named as co-inventors on the patent Italian Priority N. 102022000026595 “New inhibitors of epigenetic regulators/nuovi inibitori di regolatori epigenetici”. The other authors declare no competing interests.
